Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 14.09.2026 1 AJR Am J Roentgenol 1 BJU Int 1 Eur J Radiol 4 Eur Urol 2 Int J Urol 1 J Natl Cancer Inst 4 J Nucl Med 2 J Urol 2 Magn Reson Imaging 2 Oncogene 1 PLoS Comput Biol 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Prostate 3 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. TSAI LL
   Turfing TURPs: Should We Use MRI to Triage Incidental Low-Grade Prostate Cancer?
   AJR Am J Roentgenol. 2026 Sep 9. doi: 10.2214/AJR.26.35856.
   PubMed        
   
   

   
   BJU Int

2. HIRTSIEFER C, Kummel E, Vogelgesang A, Falkenbach F, et al
   Function drives 1-year decision regret in radical prostatectomy: a multicentre prospective study.
   BJU Int. 2026;138:694-704.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

3. VAN MOSSEL S, van der Velden KJM, Kleiburg F, Bosch D, et al
   Laying the groundwork for future health economic evaluation of [(18)F]PSMA PET/CT in guiding treatment decisions for metastatic castration-resistant prostate cancer patients.
   Eur J Radiol. 2026;205:113213.
   PubMed         Abstract available
   
   

   
   Eur Urol

4. CHERNYSHEVA D, Di Bello F, Avesani G, Baboudjian M, et al
   ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.
   Eur Urol. 2026;90:212-224.
   PubMed         Abstract available
   
   
5. GRAY S, Dutey-Magni P, Jones C, Murphy LR, et al
   Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform.
   Eur Urol. 2026 Sep 8:S0302-2838(26)02355-9. doi: 10.1016/j.eururo.2026.
   PubMed         Abstract available
   
   
6. NGUYEN DD, Najafabadi BT, Rosella LC, Dahm P, et al
   Reply to T. Takahashi's Letter to the Editor re: Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Met
   Eur Urol. 2026 Sep 9:S0302-2838(26)02274-8. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   
7. VAN AS N, Tree A, Ost P
   Re: Light A, Peters M, Gopalakrishnan A, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Regi
   Eur Urol. 2026 Sep 10:S0302-2838(26)02356-0. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   

   
   Int J Urol

8. WENZEL M, Miyajima K, Filzmayer M, Merseburger AS, et al
   Cancer-Control Outcomes of Japanese Vs. German Metastatic Hormone-Sensitive Prostate Cancer Patients: A Real-World Cross-Country Comparison of Patients Undergoing Combination Therapies.
   Int J Urol. 2026;33:e70633.
   PubMed         Abstract available
   
   
9. KANO H, Izumi K, Nakagawa R, Kamijima T, et al
   Visceral Fat Volume and Inguinal Hernia After Robot-Assisted Radical Prostatectomy: A Three-Dimensional CT Analysis.
   Int J Urol. 2026;33:e70631.
   PubMed         Abstract available
   
   

   
   J Natl Cancer Inst

10. HA A, Arbet J, Qiu Z, Khoo A, et al
    Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome.
    J Natl Cancer Inst. 2026 Sep 11:djag329. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Nucl Med

11. FENDLER WP, Hofman MS, Kersting D, Calais J, et al
    Pivotal Phase 3 Theranostic Trials: Future Indications.
    J Nucl Med. 2026;67.
    PubMed         Abstract available
    
    
12. WANG Y, McKenzie J, Sandhu S
    Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.
    J Nucl Med. 2026;67.
    PubMed         Abstract available
    
    
13. TOLMEIJER SH, Kwan EM, Gafita A, Hamid AA, et al
    Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
    J Nucl Med. 2026 Sep 10:jnumed.126.273266. doi: 10.2967/jnumed.126.273266.
    PubMed         Abstract available
    
    
14. LINDENBERG L, Huang E, Ulaner GA, Patel KR, et al
    Quantitative Thresholds on (18)F-DCFPyL PET for Determining Malignancy in Prostate Cancer with Pathologic Correlation.
    J Nucl Med. 2026 Sep 10:jnumed.126.272271. doi: 10.2967/jnumed.126.272271.
    PubMed         Abstract available
    
    

    
    J Urol

15. STARR S, Brisbane WG, Eggener S
    "Focal Vapor Ablation of Prostate Cancer: Solid or Will It Evaporate With Time?".
    J Urol. 2026 Sep 10:101097JU0000000000005301. doi: 10.1097/JU.0000000000005301.
    PubMed        
    
    
16. BULLER DM, Dubovic V, Martin WE, Rosenfeld B, et al
    Multi-Institutional Assessment of Performance Metrics for MRI-Targeted Transperineal Prostate Biopsy.
    J Urol. 2026;216:511-517.
    PubMed         Abstract available
    
    

    
    Magn Reson Imaging

17. CHEN H, Feng X, Liu C, Zhu Q, et al
    Comparison of diffusion-relaxation correlation spectrum imaging and conventional quantitative MRI parameters in differentiating between benign prostatic hyperplasia and prostate cancer: A prospective study.
    Magn Reson Imaging. 2026 Sep 11:110799. doi: 10.1016/j.mri.2026.110799.
    PubMed         Abstract available
    
    
18. CHU RJ, Jambor I, Ettala O, Taimen P, et al
    Feasibility and repeatability of DWI-derived diffusion heterogeneity for discriminating clinically significant prostate cancer.
    Magn Reson Imaging. 2026 Sep 11:110800. doi: 10.1016/j.mri.2026.110800.
    PubMed         Abstract available
    
    

    
    Oncogene

19. SONG L, Song Y, Nguyen V, Xu S, et al
    The establishment of prostate-specific, SKP2 humanized mice by CRISPR knock-in method reveals neoplastic initiation and microenvironmental reprogramming.
    Oncogene. 2026;45:3984-3996.
    PubMed         Abstract available
    
    
20. XIE T, Peng T, Li Q, Li M, et al
    Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.
    Oncogene. 2026 Sep 11. doi: 10.1038/s41388-026-03976.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

21. YUAN Z, Zhang X, Lin G, Zou Q, et al
    AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.
    PLoS Comput Biol. 2026;22:e1014703.
    PubMed         Abstract available
    
    

    
    PLoS One

22. GEIS J, Smith JF, Maddala T, Thoreson G, et al
    Uncovering the diagnostic potential of seminal fluid beyond fertility: cfDNA methylation analysis for the detection of clinically significant prostate cancer.
    PLoS One. 2026;21:e0356387.
    PubMed         Abstract available
    
    
23. PIRMORADI S, Vaghefi Moghaddam S, Ardalan M, Sharifi Bonab MM, et al
    Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability.
    PLoS One. 2026;21:e0356727.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. ZHANG S, Li M, Liu M, Patten ND, et al
    Minimal-length CAG repeats in AR define a hyperactive AR-LSD1 axis driving metabolic reprogramming in prostate cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2534152123.
    PubMed         Abstract available
    
    

    
    Prostate

25. WEI J, Shi Z, Lu L, Wang J, et al
    GenProb-PCSM: A Simplified Weighted Germline Score for Prostate Cancer-Specific Mortality.
    Prostate. 2026 Sep 8. doi: 10.1002/pros.70244.
    PubMed         Abstract available
    
    

    
    Urology

26. WHITLOCK NC, Silver R, Trostel SY, Li C, et al
    Integrative Genomic Profiling of Newly Diagnosed Prostate Cancers Progressing on Surveillance.
    Urology. 2026;215:89-96.
    PubMed         Abstract available
    
    
27. LUCA D, Pensa JW, Rehmani AK, Geoghegan R, et al
    A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-ultrasound.
    Urology. 2026;215:6-10.
    PubMed         Abstract available
    
    
28. FLETCHER SA, Cotta BH, Vertosick EA, Liso N, et al
    Concordance Between MRI Findings and Targeted Biopsy for Local Recurrence Following Radical Prostatectomy.
    Urology. 2026;215:115-118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum